References
Australian Institute of Health and Welfare. (2010). Cancer in Australia in brief. Retrieved September 1, 2012 from http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442472699
Bouguermouh, S., Van, V. Q., Martel, J., Gautier, P., Rubio, M., & Sarfati, M. (2008). CD47 expression on T cell is a self-control negative regulator of type 1 immune response. J Immunol, 180(12), 8073-8082.
Brown, E., Hooper, L., Ho, T., Gersham, H. (1990). Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Bio, 111, 2785-2794.
Chao, M.P., Alizadeh, A.A., Tang, C., Myklebust, J.H., Varghese, B., Gill, S., ... Majeti, R. (2010). Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-hodgkin lymphoma. Cell, 142, 699-713. doi:10.1016/j.cell.2010.07.044
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., . . . Weissman, I. L. (2010). Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47. Sci Transl Med, 2(63), 63ra94.
Chao, M.P., Tang, C., Pachynski, R.K., Chin, R., Majeti, R., Weissman, I.L. (2011). Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood, 118, 4890-4901
Chao, M. P., Weissman, I. L., & Majeti, R. (2012). The CD47-SIRP alpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol, 24(2), 225-232. doi: 10.1016/j.coi.2012.01.010
Gersham, H.D., Goodwin, J.L., Allen, P.M., Anderson, D.C., Brown, E.J. (1989). A novel member of the integrin receptor family mediates arg-gly-asp-stimulated neutrophil phagocytosis. J Cell Bio, 108, 1935-1943.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674. doi: 10.1016/j.cell.2011.02.013
Isenberg, J. S., Roberts, D. D., & Frazier, W. A. (2008). CD47: a new target in cardiovascular therapy. Arterioscler Thromb Vasc Biol, 28(4), 615-621.
Jiang, P., Lagenaur, C.F., Narayanan V. (1999). Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem, 274 (2), 559–562
Majeti, R., Chao, M.P., Alizadeh, A.A., Pang, W.W., Jaiswal, S., Gibbs, K.D., ... Weissman, I.L. (2009). CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 138, 286-299
Matozaki, T., Murata, Y., Okazawa, H., Ohnishi, H. (2008). Functions and molecular mechanisms of the CD47-SIRPα signalling pathway. Trends Cell Biol, 19(2), 72-80
Muruta, T. (2006). CD47 promotes neuronal development through Src- and FRG/Vav2 mediated activation of Rac and Cdc42. J Neurosci, 26, 12397-12407
Okazawa, H., Motegi, S., Ohyama, N., Ohnishi, H., Tomizawa, T., Kaneko, Y., Oldenborg, P., Ishikawa, O., Motozaki, T. (2005). Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immuno, 174, 2004-2011
Oldenbord, P.A., Zheleznyak, A., Fang, Y.F., Lagenaur, C.F., Gersham, H.D., Lindberg, F.P. (2000). Role of CD47 as a marker of self on red blood cells. Science, 288, 2051- 2054.
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000). Role of CD47 as a Marker of Self on Red Blood Cells. Science, 288(5473), 2051-2054.
Paddock, C. (2012). Antibody Shrinks Tumors Of Seven Cancers. Retrieved April 25, 2012 from http://www.medicalnewstoday.com/articles/243455.php
Rebres, R. A., Kajihara, K., & Brown, E. J. (2005). Novel CD47-dependent intercellular adhesion modulates cell migration. J Cell Physiol, 205(2), 182-193
Spaargaren, M. (2011) Lymphoma spread? Target CD46-SIRPα! Blood, 118(18), 4762-4764
Takada, T., Matozaki, T., Takeda, H., Fukunaga, K., Noguchi, T., Fujioka, Y., Okazaki, I., Tsuda, M., Yamao, T., Ochi, F. (1998). Roles of complex formation of SHPS-1 with SHP-2 in insulin stimulated mitogen-activated protein kinase activation. J Biol Chem, 273, 9234-9242
Willingham, S.B., Volkmer, J.P., Gentles, A.J., Sahoo, D., Delerba, P., Mitra, S.S., ... Weissman, I.L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PNAS, 109, 6662-6667
World Health Organisation. (2012). Cancer. Retrieved September 1, 2012 from http://www.who.int/mediacentre/factsheets/fs297/en/
Bouguermouh, S., Van, V. Q., Martel, J., Gautier, P., Rubio, M., & Sarfati, M. (2008). CD47 expression on T cell is a self-control negative regulator of type 1 immune response. J Immunol, 180(12), 8073-8082.
Brown, E., Hooper, L., Ho, T., Gersham, H. (1990). Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Bio, 111, 2785-2794.
Chao, M.P., Alizadeh, A.A., Tang, C., Myklebust, J.H., Varghese, B., Gill, S., ... Majeti, R. (2010). Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-hodgkin lymphoma. Cell, 142, 699-713. doi:10.1016/j.cell.2010.07.044
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., . . . Weissman, I. L. (2010). Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47. Sci Transl Med, 2(63), 63ra94.
Chao, M.P., Tang, C., Pachynski, R.K., Chin, R., Majeti, R., Weissman, I.L. (2011). Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood, 118, 4890-4901
Chao, M. P., Weissman, I. L., & Majeti, R. (2012). The CD47-SIRP alpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol, 24(2), 225-232. doi: 10.1016/j.coi.2012.01.010
Gersham, H.D., Goodwin, J.L., Allen, P.M., Anderson, D.C., Brown, E.J. (1989). A novel member of the integrin receptor family mediates arg-gly-asp-stimulated neutrophil phagocytosis. J Cell Bio, 108, 1935-1943.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674. doi: 10.1016/j.cell.2011.02.013
Isenberg, J. S., Roberts, D. D., & Frazier, W. A. (2008). CD47: a new target in cardiovascular therapy. Arterioscler Thromb Vasc Biol, 28(4), 615-621.
Jiang, P., Lagenaur, C.F., Narayanan V. (1999). Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem, 274 (2), 559–562
Majeti, R., Chao, M.P., Alizadeh, A.A., Pang, W.W., Jaiswal, S., Gibbs, K.D., ... Weissman, I.L. (2009). CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 138, 286-299
Matozaki, T., Murata, Y., Okazawa, H., Ohnishi, H. (2008). Functions and molecular mechanisms of the CD47-SIRPα signalling pathway. Trends Cell Biol, 19(2), 72-80
Muruta, T. (2006). CD47 promotes neuronal development through Src- and FRG/Vav2 mediated activation of Rac and Cdc42. J Neurosci, 26, 12397-12407
Okazawa, H., Motegi, S., Ohyama, N., Ohnishi, H., Tomizawa, T., Kaneko, Y., Oldenborg, P., Ishikawa, O., Motozaki, T. (2005). Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immuno, 174, 2004-2011
Oldenbord, P.A., Zheleznyak, A., Fang, Y.F., Lagenaur, C.F., Gersham, H.D., Lindberg, F.P. (2000). Role of CD47 as a marker of self on red blood cells. Science, 288, 2051- 2054.
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000). Role of CD47 as a Marker of Self on Red Blood Cells. Science, 288(5473), 2051-2054.
Paddock, C. (2012). Antibody Shrinks Tumors Of Seven Cancers. Retrieved April 25, 2012 from http://www.medicalnewstoday.com/articles/243455.php
Rebres, R. A., Kajihara, K., & Brown, E. J. (2005). Novel CD47-dependent intercellular adhesion modulates cell migration. J Cell Physiol, 205(2), 182-193
Spaargaren, M. (2011) Lymphoma spread? Target CD46-SIRPα! Blood, 118(18), 4762-4764
Takada, T., Matozaki, T., Takeda, H., Fukunaga, K., Noguchi, T., Fujioka, Y., Okazaki, I., Tsuda, M., Yamao, T., Ochi, F. (1998). Roles of complex formation of SHPS-1 with SHP-2 in insulin stimulated mitogen-activated protein kinase activation. J Biol Chem, 273, 9234-9242
Willingham, S.B., Volkmer, J.P., Gentles, A.J., Sahoo, D., Delerba, P., Mitra, S.S., ... Weissman, I.L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PNAS, 109, 6662-6667
World Health Organisation. (2012). Cancer. Retrieved September 1, 2012 from http://www.who.int/mediacentre/factsheets/fs297/en/